Characterization of drug-resistant influenza virus A(H1N1) and A(H3N2) variants selected in vitro with laninamivir.

Samson, Mélanie; Abed, Yacine; Desrochers, François-Marc; Hamilton, Stephanie; Luttick, Angela; Tucker, Simon P; Pryor, Melinda J; Boivin, Guy

Samson, Mélanie; Abed, Yacine; Desrochers, François-Marc; Hamilton, Stephanie; Luttick, Angela; Tucker, Simon P; Pryor, Melinda J; Boivin, Guy.

Affiliation

Samson M; Research Center in Infectious Diseases of the CHU de Québec-CHUL and Laval University, Québec City, Québec, Canada.
Abed Y; Research Center in Infectious Diseases of the CHU de Québec-CHUL and Laval University, Québec City, Québec, Canada.
Desrochers FM; Research Center in Infectious Diseases of the CHU de Québec-CHUL and Laval University, Québec City, Québec, Canada.
Hamilton S; Biota Scientific Management, Notting Hill, Australia.
Luttick A; Biota Scientific Management, Notting Hill, Australia.
Tucker SP; Biota Scientific Management, Notting Hill, Australia.
Pryor MJ; Biota Scientific Management, Notting Hill, Australia.
Boivin G; Research Center in Infectious Diseases of the CHU de Québec-CHUL and Laval University, Québec City, Québec, Canada Guy.Boivin@crchul.ulaval.ca.

Antimicrob Agents Chemother ; 58(9): 5220-8, 2014 Sep.

Article de En | MEDLINE | ID: mdl-24957832

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Antiviraux / Sous-type H1N1 du virus de la grippe A / Sous-type H3N2 du virus de la grippe A / Zanamivir Limites: Humans Langue: En Journal: Antimicrob Agents Chemother Année: 2014 Type de document: Article Pays d'affiliation: Canada Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google